Extracellular Matrix-MYCAF Signatures Correlate with Resistance to Neoadjuvant aPD-L1 Immune Checkpoint Inhibition with Durvalumab + Metformin in HPV+ HNSCC
细胞外基质-MYCAF 特征与 HPV 阳性头颈部鳞状细胞癌患者对新辅助 PD-L1 免疫检查点抑制剂度伐利尤单抗联合二甲双胍治疗的耐药性相关
期刊:Clinical Cancer Research
影响因子:
doi:10.1158/1078-0432.CCR-25-1098
Llerena, Pablo; Samarah, Hani; Nunes, Kathryn; Lin, Zhao; Bridgham, Kelly; Tekumalla, Sruti; Jain, Amiti; Harshyne, Larry; Shukla, Sanket K; Vathiotis, Ioannis; Tuluc, Madalina; Gargano, Stacey; Eisenbrey, John R; Keith, Scott; Cognetti, David M; Bar-Ad, Voichita C; Luginbuhl, Adam J; Axelrod, Rita; Vadigepalli, Rajanikanth; Yang, Hushan; Whitaker-Menezes, Diana; Roche, Megan; Mahoney, My G; Argiris, Athanassios; Solomides, Charalambos; Johnson, Jennifer M; Barbirou, Mouadh; Miller, Amanda; South, Andrew P; Mitra, Ramkrishna; Linnenbach, Alban J; Martinez-Outschoorn, Ubaldo; Curry, Joseph M
Checkpoint
肿瘤
肿瘤免疫
PD-L1
细胞生物学
MYC
免疫/内分泌